Genetic Technologies Ltd (GTG)

0.004
0.000(0.00%)
  • Volume:
    90,957
  • Bid/Ask:
    0.003/0.004
  • Day's Range:
    0.004 - 0.004

GTG Overview

Prev. Close
0.004
Day's Range
0.004-0.004
Revenue
2.15M
Open
0.004
52 wk Range
0.003-0.009
EPS
0
Volume
90,957
Market Cap
36.94M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
3,526,639
P/E Ratio
-
Beta
1.6
1-Year Change
-42.86%
Shares Outstanding
9,233,965,143
Next Earnings Date
-
What is your sentiment on Genetic Technologies Ltd?
or
Market is currently closed. Voting is open during market hours.

Genetic Technologies Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Genetic Technologies Ltd Company Profile

Genetic Technologies Ltd Company Profile

Genetic Technologies Limited (GTG) is an Australia-based diversified molecular diagnostics company. The Company is focused on the development and commercialization of genetic risk assessment technology. The Company is engaged in providing genomics-based tests in health, wellness and serious disease through its GeneType and EasyDNA brands. GTG is focused on developing an integrated predictive genetic testing and assessment tools enabling medical practitioners and their patients to proactively manage health. The Company’s geneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type two diabetes in a single test. The GeneType offers integrated risk testing for a range of serious conditions. GTG offers cancer predictive testing and assessment tools for physicians. Its Polygenic Risk Scores (PRS) platform offers integrated clinical and genetic risk delivering actionable outcomes from physicians and individuals.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsNeutralNeutralNeutralBuyStrong Sell
SummaryBuyBuyBuyStrong BuyStrong Sell
  • why still halted
    0
    • why still halted
      0